GSTM1 and neoplasm: Harnessing the O2-carrying abilities of Hb coupled to HSA’s tumor-targeting properties, the MnPcS@HPO NPs successfully targeted cancerous niches, relieved hypoxia and improved SDT anticancer activity (Fig. 7e(iii-v)) [68].